Glow Lifetech Corp. (GLOW.CN)
CAD 0.06
(0.0%)
CAD 0.06
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 116.15 Thousand CAD | -81.18% |
| 2022 | 617.04 Thousand CAD | 187.39% |
| 2021 | -706.08 Thousand CAD | -15449.76% |
| 2020 | 4600.00 CAD | 132.74% |
| 2019 | -14.05 Thousand CAD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 388.4 Thousand CAD | 234.4% |
| 2024 Q2 | -7033.00 CAD | -101.81% |
| 2023 Q2 | 949.54 Thousand CAD | 41.69% |
| 2023 Q4 | 116.15 Thousand CAD | -88.74% |
| 2023 FY | 116.15 Thousand CAD | -81.18% |
| 2023 Q1 | 670.14 Thousand CAD | 8.61% |
| 2023 Q3 | 1.03 Million CAD | 8.61% |
| 2022 Q3 | 272.66 Thousand CAD | 2455.88% |
| 2022 Q1 | -167.56 Thousand CAD | 76.27% |
| 2022 FY | 617.04 Thousand CAD | 187.39% |
| 2022 Q4 | 617.04 Thousand CAD | 126.31% |
| 2022 Q2 | 10.66 Thousand CAD | 106.37% |
| 2021 Q1 | -2.94 Million CAD | -64098.35% |
| 2021 FY | -706.08 Thousand CAD | -15449.76% |
| 2021 Q3 | -1.38 Million CAD | 30.92% |
| 2021 Q2 | -2 Million CAD | 31.77% |
| 2021 Q4 | -706.08 Thousand CAD | 49.11% |
| 2020 Q2 | 3834.00 CAD | -2.44% |
| 2020 Q4 | 4600.00 CAD | -23.22% |
| 2020 Q1 | 3930.00 CAD | 127.97% |
| 2020 Q3 | 5991.00 CAD | 56.26% |
| 2020 FY | 4600.00 CAD | 132.74% |
| 2019 Q4 | -14.05 Thousand CAD | 0.0% |
| 2019 FY | -14.05 Thousand CAD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Algernon Pharmaceuticals Inc. | -125.08 Thousand CAD | 192.857% |
| Asep Medical Holdings Inc | -44.72 Thousand CAD | 359.721% |
| BetterLife Pharma Inc. | 207.85 Thousand CAD | 44.118% |
| BioVaxys Technology Corp. | -977.00 CAD | 11988.434% |
| ChitogenX Inc. | 3.84 Million CAD | 96.975% |
| Rapid Dose Therapeutics Corp. | 2.29 Million CAD | 94.934% |
| Defence Therapeutics Inc. | 1.68 Million CAD | 93.127% |
| Entheon Biomedical Corp. | -344.63 Thousand CAD | 133.703% |
| Gemina Laboratories Ltd. | 284.33 Thousand CAD | 59.15% |
| Lexston Life Sciences Corp. | -390.4 Thousand CAD | 129.751% |
| Pharmala Biotech Holdings Inc. | 58.49 Thousand CAD | -98.564% |
| Doseology Sciences Inc. | -1.06 Million CAD | 110.955% |
| MYND Life Sciences Inc. | 2.99 Million CAD | 96.128% |
| Nova Mentis Life Science Corp. | -8088.00 CAD | 1536.078% |
| PharmaTher Holdings Ltd. | -2.13 Million CAD | 105.445% |
| PreveCeutical Medical Inc. | 3.83 Million CAD | 96.97% |
| Telescope Innovations Corp. | -719.49 Thousand CAD | 116.143% |